Texas 2013 83rd Regular

Texas Senate Bill SB190 Engrossed / Fiscal Note

Filed 02/01/2025

Download
.pdf .doc .html
                    LEGISLATIVE BUDGET BOARD    Austin, Texas      FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION            May 6, 2013      TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Engrossed    No significant fiscal implication to the State is anticipated.  The bill would amend the Occupations Code relating to the prescription and pharmaceutical substitution of biological products. Based on information provided by the Board of Pharmacy, it is assumed that the provisions of the bill could be implemented by utilizing existing agency resources. Local Government Impact No fiscal implication to units of local government is anticipated.    Source Agencies:515 Board of Pharmacy   LBB Staff:  UP, CL, MW, ED    

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 83RD LEGISLATIVE REGULAR SESSION
May 6, 2013





  TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health      FROM: Ursula Parks, Director, Legislative Budget Board     IN RE:SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Engrossed  

TO: Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Engrossed

 Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health 

 Honorable Lois W. Kolkhorst, Chair, House Committee on Public Health 

 Ursula Parks, Director, Legislative Budget Board

 Ursula Parks, Director, Legislative Budget Board

SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Engrossed

SB190 by Huffman (Relating to the prescription and pharmaceutical substitution of biological products.), As Engrossed



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.



The bill would amend the Occupations Code relating to the prescription and pharmaceutical substitution of biological products. Based on information provided by the Board of Pharmacy, it is assumed that the provisions of the bill could be implemented by utilizing existing agency resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies: 515 Board of Pharmacy

515 Board of Pharmacy

LBB Staff: UP, CL, MW, ED

 UP, CL, MW, ED